The Role and Power of Digitalization: Insights from a Panel Discussion

As we continue to forge ahead into an era where technology seamlessly integrates into every aspect of healthcare, TURBOARD had the privilege of moderating an enlightening panel discussion titled “The Role and Power of Digitalization” during the Bahrain C3 Summit 2024 on the future of healthcare technology.

Opening Remarks

Our Co-founder & CEO, Yasemin Sahin, opened the session by sharing insights from her journey in the tech industry. She highlighted TURBOARD's significant contributions to healthcare through data analytics and business intelligence, emphasizing projects like the comorbidity index scoring system and predictive analytics models that have markedly improved patient outcomes and operational efficiencies.

Insights from the Panel

The discussion featured esteemed panelists such as Dr. Ronald M. Razmi, Mr. Essam Algobaisi, and Dr. Jacob Sands, who brought diverse perspectives from their respective fields.

Dr. Ronald M. Razmi shared his transition from cardiology to AI, focusing on the intersection of medical knowledge and technological innovation. He discussed his role at Zoi Capital and his upcoming book, which explores the transformative impact of AI in healthcare.

Mr. Essam Algobaisi highlighted his role in shaping international health policies and his insights on the integration of digital health technologies into global health initiatives and educational programs, particularly emphasizing their importance in achieving Sustainable Development Goals.

Dr. Jacob Sands discussed the innovative use of digital platforms in lung cancer care. He emphasized how digital tools like the 'Lung Cancer Living Room' episodes on YouTube can enhance patient education and empowerment, making a significant impact by connecting patients with professionals and each other in meaningful ways.

Key Takeaways

The panelists collectively underscored the potential of digitalization to transform healthcare delivery through enhanced diagnostic tools, personalized medicine, and more effective patient engagement strategies. They stressed the importance of maintaining a human-centered approach amidst the rapid integration of digital solutions.

Closing Thoughts

In her closing remarks, Yasemin reflected on the profound insights shared by the panelists and the impactful discussions that had taken place. She reaffirmed TURBOARD's commitment to leveraging technology to improve healthcare outcomes, emphasizing the importance of innovative solutions that are both effective and empathetic.

As we look toward the future, the role of digitalization in healthcare promises not only to enhance operational efficiencies and patient care but also to reshape the very fabric of the healthcare industry. TURBOARD remains at the forefront, ready to embrace these changes and continue driving advancements that benefit healthcare providers and patients alike.

About Moderator and Panelists

Moderator Ms. Yasemin Sahin, CEO & Co-Founder, TURBOARD, Turkey	Mrs. Sahin is the CEO and Co-Founder of TURBOARD, an innovative Business Intelligence and analytics company that enables its users to communicate effectively, using data to tell stories, develop insights and strategy, and gain a competitive advantage.As the CEO of the Company, Mrs. Sahin has created unique opportunities leveraging the Company’s scale to build, expand, operate and globalize the business. An entrepreneur dedicated to creating value for her clients; goals for her teams, Mrs. Sahin is a pioneer who combines her strong knowledge and background in the IT sector with finance and business development to create TURBOARD, the next generation BI and data analytics providing platform. She has patented a system in TURBOARD to build a global sales, technical and finance team with a platform committed to providing high quality products with superior service. With 16+ years experience in the IT industry, she is a Visionary Entrepreneur, Strategist and a highly motivated, result oriented, ambitious and passionate executive. Disrupting the sector with Mrs. Sahin’s state of the art technologies, competitive price points and excellent customer service solutions, TURBOARD is one of the leading Analytics startups in the world. She is an innovator, business leader, financier and a talented entrepreneur recognized for her product and technology innovations, leadership talents, business formulations skills and focus on BI investments. Today, Mrs. Sahin’s analytics platform is used by more than 400,000 users all over the world.
Panelist Dr. Ronald M. Razmi, MD, Managing Director, Zoi Capital, USA	Dr. Razmi has a distinguished career that blends his medical expertise with technological innovation. Originally a cardiologist, Dr. Razmi was a trailblazer in using MRI technology for cardiac care. His transition into the AI field is driven by a desire to infuse his medical knowledge into technological advancements. At Zoi Capital, he plays a pivotal role in transforming the industry by developing AI solutions that are grounded in real-world expertise and address genuine needs. His forthcoming book, AI Doctor: The Rise of Artificial Intelligence in Healthcare, is a testament to his commitment to this field. Additionally, his extensive contributions to digital health are evident through numerous publications in esteemed scientific journals and his active participation as a speaker and writer in the digital health arena.
Panelist Mr. Essam Algobaisi, CEO, Business Intelligence Group, KSA	Essam Algobaisi is a dynamic leader with a comprehensive background in strategic planning, project management, and international relations. He actively represents the Kingdom of Saudi Arabia in various international forums and is a key member of several committees at the Bureau of Experts at the Saudi Council of Ministers. His expertise includes leadership, public speaking, and international project management, making significant contributions to both local and global platforms.
Panelist Dr. Jacob Sands, Oncology Medical Director, International Patient Center, Dana-Farber Cancer Institute, Assistant Professor, Harvard Medical School, USA	Dr. Jacob Sands, M.D., is a thoracic medical oncologist at Dana-Farber Cancer Institute and an assistant professor of medicine at Harvard Medical School. He serves as Oncology Medical Director of the Dana-Farber International Patient Center. He received his medical degree from the University of Cincinnati before completing residency in internal medicine and fellowship training in hematology/oncology at the University of California, Davis. Dr. Sands joined Dana-Farber Cancer Institute in 2017 where he sees individuals with lung cancer and leads the small cell lung cancer clinical research program. He is a member of the NCCN guidelines committees on small cell lung cancer and lung screening. Dr. Sands has given many invited talks on various aspects of lung cancer as well as talks with the public and patient advocacy organizations, such as a discussion on clinical trials for the Bonnie Addario Foundation “Living Room.” During the five years he was on staff at Lahey Hospital & Medical Center, Dr. Sands was a member of the steering committee that initiated a community benefit of lung screening, which developed into a lung screening program that many consider to be a model for other institutions. He is a co-founder and President of the Rescue Lung Rescue Life Society, a non-profit organization focused on increasing implementation of lung screening and pioneering early detection innovations.